INVESTORS & MEDIA
SEC Filing Details
SEC Filing Details
Document Details
Form
Filing Date
Feb 8, 2023
Document Date
Feb 6, 2023
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Regeneron Pharmaceuticals Inc.
Issuer
REGENERON PHARMACEUTICALS, INC.
Filer
GOLDSTEIN JOSEPH L